Free Trial

$750M Quest Diagnostics, $1B Arthur Gallagher 2Pt Launched

PIPELINE
  • Date $MM Issuer (Priced *, Launch #)
  • 10/30 $750M #Quest Diagnostics 10Y +153
  • 10/30 $1B #Arthur Gallagher $400M +10Y +163, $600M +30Y +178
  • 10/30 $Benchmark Morgan Stanley 3Y +100a, 3Y SOFR+120a, 6NC5 +160a, 11NC10 +175a
  • 10/30 $Benchmark Santander 4NC3 +175a, 4NC3 SOFR, 5Y +190a, 10Y +215a
  • 10/30 $Benchmark Bristol-Myers 7Y +100a, 10Y +115a, 30Y +135a, 40Y +150a
  • 10/30 $Benchmark Altria Grp 5Y +160a, 10y +225a
  • 10/30 $Benchmark Bimbo Bakeries US +5Y +140a, +10Y +165a
  • 10/30 $Benchmark Hyundai 2Y +125a, 2Y SOFR, +5Y +195a, +5Y SOFR
  • 10/30 $Benchmark Canadian National 10Y +125a, 30Y +140a
  • 10/30 $Benchmark Ryder 5Y +160a, 10Y +190a

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.